The Enterprise Value as of November 2024 (TTM) for Metacrine, Inc. (MTCR) is -41431147.00

According to Metacrine, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -41431147.00. This represents a change of 472.10% compared to the average of -7241955.61 of the last 4 quarters.

Metacrine, Inc. (MTCR) Historical Enterprise Value (quarterly & annually)

How has MTCR Enterprise Value performed in the past?

The mean historical Enterprise Value of Metacrine, Inc. over the last ten years is 96.32M. The current -41431147.00 Enterprise Value has changed -4401.53% with respect to the historical average. Over the past ten years (40 quarters), MTCR's Enterprise Value was at its highest in in the June 2020 quarter at 299.02M. The Enterprise Value was at its lowest in in the September 2020 quarter at -74165285.72.

Metacrine, Inc. (MTCR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Metacrine, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Metacrine, Inc. (MTCR) Average Enterprise Value

How has MTCR Enterprise Value performed in the past?

The current Enterprise Value of Metacrine, Inc. (MTCR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Metacrine, Inc. (MTCR) Enterprise Value vs. Peers

How is MTCR’s Enterprise Value compared to its peers?

Metacrine, Inc.’s Enterprise Value is greater than Magenta Therapeutics, Inc. (-114170976.00), less than Protara Therapeutics, Inc. (-31165818.00), less than TRACON Pharmaceuticals, Inc. (-6133696.00), less than Satsuma Pharmaceuticals, Inc. (17.06M), less than Neoleukin Therapeutics, Inc. (-6333315.00), less than CytomX Therapeutics, Inc. (47.40M), less than Assembly Biosciences, Inc. (90.29M), less than Instil Bio, Inc. (258.54M), less than Nuvation Bio Inc. (1.02B), less than Vaccinex, Inc. (8.95M), less than Monopar Therapeutics Inc. (81.10M), less than Miromatrix Medical Inc. (90.06M), less than Surrozen, Inc. (2.49M), less than Anebulo Pharmaceuticals, Inc. (45.92M), less than ZIVO Bioscience, Inc. (69.40M), less than Indaptus Therapeutics, Inc. (4.76M),

Build a custom stock screener for Metacrine, Inc. (MTCR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Metacrine, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Metacrine, Inc. (MTCR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Metacrine, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.